Stable, concentrated radionuclide complex solutions
US12415003B2 · kind B2 · utility
0Cited by
12References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 25, 2024 |
| Grant date | Sep 16, 2025 |
| Priority date | — |
| Expiry date | Oct 25, 2044 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K51/0482
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to radionuclide complex solutions of high concentration and of high chemical stability, that allows their use as drug product for diagnostic and/or therapeutic purposes. The stability of the drug product is achieved by at least one stabilizer against radiolytic degradation. The use of two stabilizers introduced during the manufacturing process at different stages was found to be of particular advantage.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.